Chemily Glycoscience, is a research, development and consulting company focusing on glyco-related enzymes, cost-effective synthesis of glycan libraries and carbohydrate-based biochemicals and pharmaceuticals.

Glycomic analysis

Our team, with years of experience in glycomics and proteomics technology, provides reliable analysis and will work in partnership to accelerate your research.

Glycobiology Reagents

We serve a library of specialty glycans, glycosyltransferases, oligosaccharides and other biochemicals to major vendors like Sigma-Aldrich, and directly to you!

Custom Synthesis

We offer on-demand synthesis of custom glycans, glycopeptides, glycoproteins, and glycoconjugates.  Can’t find what you’re looking for? Just ask!

Chemily Glycoscience is developing into a major supplier for carbohydrate-based biochemicals, reagents and pharmaceuticals, and has been manufacturing several categories of products using it’s proprietary chemo-enzymatic and in vivo bioengineering technology. Some of the new developments include:

  1. Structure-defined oligosaccharides and glycolipids;
  2. Immunogenic bacterial cell surface polysaccharides;
  3. Sugar nucleotides and their derivatives;
  4. Carbohydrate-based pharmaceuticals and glycoprotein vaccines;
  5. Carbohydrate related enzymes, such as glycosyltransferases, glycosyl hydrolases, sugar nucleotide biosynthesized enzymes.

Based on its proprietary carbohydrate and uncommon sugar library (deposits), Chemily Glycoscience has been developing sugar-containing small molecules in therapeutic treatment options in two core disease areas: cancer and cardiovascular diseases. Recently, Chemily has also been licensing and developing novel glycoconjugation technology to produce polysaccharide-protein conjugate vaccines and therapeutic glycoproteins at unprecedented cost-effective levels.

Get the latest news in Glycoscience with our newsletter!

Click here to add your own text

© Copyright 2016 - Chemily Glycoscience
Check out our new package deals!